A survey on menstrual re-start after GnRH agonist therapy for young women with cancer and autoimmune diseases

A survey on menstrual re-start after GnRH agonist therapy for young women with cancer and autoimmune diseases - A survey on menstrual re-start after GnRH agonist therapy for young women with cancer and autoimmune diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034096

Enrollment

100

Registered

2018-09-12

Start date

2018-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature ovarian failure

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who did not receive GnRH therapy for ovarian protection in young women who received chemotherapy in the past

Exclusion criteria

Exclusion criteria: before meniscal over 41 years old

Design outcomes

Primary

Measure	Time frame
We report the results after 4 weeks from the start of the survey.	—

Countries

Japan

Contacts

Public ContactAkihito Horie

Kyoto University Hospital Consultation support center

ctsodan@kuhp.kyoto-u.ac.jp075-751-4748

Outcome results